Yan Meng

682 total citations
27 papers, 521 citations indexed

About

Yan Meng is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yan Meng has authored 27 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yan Meng's work include Cancer, Hypoxia, and Metabolism (3 papers), Cell Adhesion Molecules Research (3 papers) and Anesthesia and Neurotoxicity Research (2 papers). Yan Meng is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Cell Adhesion Molecules Research (3 papers) and Anesthesia and Neurotoxicity Research (2 papers). Yan Meng collaborates with scholars based in China, Vietnam and Thailand. Yan Meng's co-authors include Cui Tian, Hui‐Hua Li, Jie Du, Yuanyuan Zheng, Chen Chen, Yanwen Qin, Yuehong Zheng, Zhenqiang Gao, Xiyu Zhang and Lei Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and European Heart Journal.

In The Last Decade

Yan Meng

24 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Meng China 12 210 130 101 90 84 27 521
Rachael E. Redgrave United Kingdom 12 282 1.3× 94 0.7× 112 1.1× 66 0.7× 62 0.7× 18 731
Tong Huan Jin China 9 242 1.2× 282 2.2× 102 1.0× 92 1.0× 52 0.6× 15 684
Qin Yi China 16 313 1.5× 89 0.7× 56 0.6× 130 1.4× 45 0.5× 42 510
Ming-Hui Zheng China 16 399 1.9× 75 0.6× 67 0.7× 175 1.9× 93 1.1× 32 684
Monika Maleszewska Germany 9 497 2.4× 112 0.9× 113 1.1× 155 1.7× 54 0.6× 13 730
Ying Gao China 11 147 0.7× 146 1.1× 43 0.4× 67 0.7× 58 0.7× 55 453
C Wang China 13 267 1.3× 59 0.5× 65 0.6× 153 1.7× 163 1.9× 39 553
Gwon‐Soo Jung South Korea 15 229 1.1× 58 0.4× 71 0.7× 69 0.8× 104 1.2× 27 591
Honglin Dong China 10 189 0.9× 115 0.9× 94 0.9× 107 1.2× 38 0.5× 36 494
Sheng‐an Su China 15 453 2.2× 104 0.8× 113 1.1× 79 0.9× 80 1.0× 21 784

Countries citing papers authored by Yan Meng

Since Specialization
Citations

This map shows the geographic impact of Yan Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Meng more than expected).

Fields of papers citing papers by Yan Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Meng. The network helps show where Yan Meng may publish in the future.

Co-authorship network of co-authors of Yan Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Meng. A scholar is included among the top collaborators of Yan Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Meng. Yan Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wěi, et al.. (2025). SIRT6 Overexpression Enhances Diabetic Foot Ulcer Healing via Nrf2 Pathway Activation. Inflammation. 48(6). 3858–3877. 1 indexed citations
2.
Meng, Yan, Xiyu Zhang, Zhenqiang Gao, et al.. (2025). xCT/Slc7a11 promotes pulmonary arterial hypertension by disrupting AMPKα suppression of mTOR activation. Biochemical Pharmacology. 236. 116897–116897.
3.
Meng, Yan, et al.. (2025). Dragon’s Blood Modulates Disulfidptosis-Related Genes to Alleviate Ischemic Brain Injury in Mice. Neurochemical Research. 50(3). 185–185.
4.
Yang, Tingting, Yingkuan Shao, Cheng Qian, et al.. (2025). YY1/HIF-1α/mROS positive-feedback loop exacerbates glomerular mesangial cell proliferation in mouse early diabetic kidney disease. Acta Pharmacologica Sinica. 46(7). 1974–1989. 2 indexed citations
5.
Meng, Yan, et al.. (2024). A novel perspective in stroke neuroprotection: Leveraging hypoxic pocket insights for studying preconditioning and postconditioning. SHILAP Revista de lepidopterología. 2(4). 288–295. 1 indexed citations
6.
Zhu, Li, Yuan Zhong, Yan Meng, et al.. (2024). Macrophage Membrane-Encapsulated Dopamine-Modified Poly Cyclodextrin Multifunctional Biomimetic Nanoparticles for Atherosclerosis Therapy. ACS Applied Materials & Interfaces. 16(25). 32027–32044. 15 indexed citations
7.
Zhu, Li, Hongjiao Li, Jiyu Li, et al.. (2023). Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis. Journal of Nanobiotechnology. 21(1). 307–307. 19 indexed citations
8.
Chen, Rongrong, Hongfei Wang, Xiyu Zhang, et al.. (2023). Polo-like kinase 1 promotes pulmonary hypertension. Respiratory Research. 24(1). 204–204. 6 indexed citations
9.
Gao, Zhenqiang, Yaqi Xing, Xiyu Zhang, et al.. (2023). Polo-like kinase 1 promotes sepsis-induced myocardial dysfunction. International Immunopharmacology. 125(Pt A). 111074–111074. 6 indexed citations
10.
Xing, Yaqi, Zhenqiang Gao, Yunfei Bai, et al.. (2023). Golgi Protein 73 Promotes LPS-Induced Cardiac Dysfunction via Mediating Myocardial Apoptosis and Autophagy. Journal of Cardiovascular Pharmacology. 83(1). 116–125. 10 indexed citations
11.
Zhang, Xiyu, Zhenqiang Gao, Hongyu Chen, et al.. (2021). SLC7A11/xCT Prevents Cardiac Hypertrophy by Inhibiting Ferroptosis. Cardiovascular Drugs and Therapy. 36(3). 437–447. 79 indexed citations
12.
Zhang, Xiyu, Zhenqiang Gao, Lingling Wang, et al.. (2021). PKM2 promotes angiotensin‐II‐induced cardiac remodelling by activating TGF‐β/Smad2/3 and Jak2/Stat3 pathways through oxidative stress. Journal of Cellular and Molecular Medicine. 25(22). 10711–10723. 46 indexed citations
13.
Wang, Wei, et al.. (2019). P3485Autophagy insufficiency participates in hyperhomocysteinemia-induced cardiac aging. European Heart Journal. 40(Supplement_1). 1 indexed citations
14.
Chen, Chen, Wei Jiang, Zongjian Liu, et al.. (2018). Splenic responses play an important role in remote ischemic preconditioning-mediated neuroprotection against stroke. Journal of Neuroinflammation. 15(1). 39 indexed citations
15.
Meng, Yan, Chen Chen, Liu Yang, Cui Tian, & Hui‐Hua Li. (2017). Angiotensin II Regulates Dendritic Cells through Activation of NF-κB /p65, ERK1/2 and STAT1 Pathways. Cellular Physiology and Biochemistry. 42(4). 1550–1558. 27 indexed citations
16.
Meng, Yan, Chen Chen, Cui Tian, Jie Du, & Hui‐Hua Li. (2015). Angiotensin II-Induced Egr-1 Expression is Suppressed by Peroxisome Proliferator- Activated Receptor-γ Ligand 15d-PGJ2 in Macrophages. Cellular Physiology and Biochemistry. 35(2). 689–698. 28 indexed citations
17.
Meng, Yan, Chen Chen, Lei Wang, et al.. (2013). Toll-Like Receptor-2 Ligand Peptidoglycan Upregulates Expression and Ubiquitin Ligase Activity of CHIP through JNK Pathway. Cellular Physiology and Biochemistry. 32(4). 1097–1105. 15 indexed citations
18.
Zheng, Yuehong, Cui Tian, Yan Meng, et al.. (2011). Osteopontin stimulates autophagy via integrin/CD44 and p38 MAPK signaling pathways in vascular smooth muscle cells. Journal of Cellular Physiology. 227(1). 127–135. 123 indexed citations
19.
Yin, Jie, et al.. (2010). Clinical analysis of diagnosis and treatment of ocular adnexal mucosa-associated lymphoid tissue lymphoma.. Xiandai shengwu yixue jinzhan. 10(22). 4298–4336.
20.
Meng, Yan, et al.. (2009). Amyloid precursor protein 17-mer peptide ameliorates hippocampal neurodegeneration in ovariectomized rats. Neuroscience Letters. 468(3). 173–177. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026